Literature DB >> 3583617

Morphology of regressive changes in the kidney following experimental ischaemia.

K Fortýn, J Hradecký, V Hruban, V Horák, P Dvorák, J Tichý.   

Abstract

Total or partial renal ischaemia was studied in rats and pigs in a series of experiments, after total devascularization (ligature of renal vessels and ureter); ligature of isolated renal artery; experimental embolization of renal artery by non-resorbable material; devascularization of a specific renal segment by deep, strangulating sutures. Morphological studies showed that the resulting necrotization is represented most frequently by coagulation necrosis, less frequently by colliquating necrosis. Occlusion of the renal artery by embolization or ligature leads only to partial necrotization or atrophy. Total devascularization of the renal hilus or total devascularization of a specific renal segment by strangulating sutures leads to total destruction of the devascularized (devitalized) tissues. Within 8-12 weeks, the whole organ changes into a small residue of connective tissue. The possibility of the use of the devascularization technique in the treatment of tumours is discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3583617     DOI: 10.1007/bf02549672

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

1.  [Permanent stop of renal circulation by embolisation with microspheres. Preliminary report (author's transl)].

Authors:  K Barth; W Bischoff; G Wenzel
Journal:  Urologe A       Date:  1975-09       Impact factor: 0.639

2.  Some aspects of renal tumors with special reference to spontaneous regression.

Authors:  E LJUNGGREN; S HOLM; B KARTH; R POMPEIUS
Journal:  J Urol       Date:  1959-11       Impact factor: 7.450

3.  Percutaneous catheter-aided infarction of renal tumors: a preliminary report.

Authors:  S B Paster; P Bergreen; H Schwarz
Journal:  J Urol       Date:  1975-09       Impact factor: 7.450

4.  [Small and large intestine devascularization (devitalization) and potentials in the therapeutic use of this operative method].

Authors:  K Fortýn; J Hradecký; J Pazdera; J Klaudy; V Hruban; P Dvorák; J Matousek; J Tichý; V Kolín
Journal:  Z Exp Chir Transplant Kunstliche Organe       Date:  1985

Review 5.  Immunologic aspects of cancer.

Authors:  A M Sophocles; S H Nadler
Journal:  Surg Gynecol Obstet       Date:  1971-08

6.  Tumour-distinctive cellular immunity to renal carcinoma.

Authors:  J Stjernswärd; L E Almgård; S Franzén; T von Schreeb; L B Wadström
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

7.  Immunologic resistance to carcinoma produced by electrocoagulation.

Authors:  A A Strauss; M Appel; O Saphir; A J Rabinovitz
Journal:  Surg Gynecol Obstet       Date:  1965-11

8.  Clinical evaluation of electrocoagulation in the treatment of cancer of the rectum.

Authors:  J L Madden; S Kandalaft
Journal:  Am J Surg       Date:  1971-09       Impact factor: 2.565

9.  [Surgical treatment of adenocarcinoma of the kidneys after prior embolization of the renal artery].

Authors:  J Klemenc; V Simon; J Krivánek; E Votocek
Journal:  Cas Lek Cesk       Date:  1984-12-28

10.  Percutaneous angiographic embolization: a procedure of increasing usefulness: review of a decade of experience.

Authors:  F S Keller; J Rösch; G M Baur; L M Taylor; C T Dotter; J M Porter
Journal:  Am J Surg       Date:  1981-07       Impact factor: 2.565

View more
  2 in total

1.  Autologous tumor immunizing devascularization of an invasive colorectal cancer: A case report and literature review.

Authors:  Pavel Vašek; Josef Krajnik; David J Kopsky; Vladimir Kalina; Marek Frydrych
Journal:  Mol Clin Oncol       Date:  2016-09-21

Review 2.  Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma.

Authors:  Vratislav Horak; Anna Palanova; Jana Cizkova; Veronika Miltrova; Petr Vodicka; Helena Kupcova Skalnikova
Journal:  Genes (Basel)       Date:  2019-11-09       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.